Cognitive-Behavioral Therapy for Autism
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it mentions that participants can be un-medicated or on a stable medication regimen. It seems you may continue your current medications if they are stable.
What data supports the effectiveness of the treatment Cognitive-Behavioral Therapy for Autism?
Research shows that Cognitive-Behavioral Therapy (CBT) is effective in improving symptoms and functioning in conditions like schizophrenia and mood disorders, suggesting it may also help with autism. For example, a study found improvements in symptom severity and psychosocial functioning in patients with schizophrenia who received CBT.12345
Is Cognitive-Behavioral Therapy (CBT) safe for people with autism?
How is Cognitive-Behavioral Therapy (CBT) different from other treatments for autism?
Cognitive-Behavioral Therapy (CBT) is unique for autism as it is specifically adapted to help high-functioning children with autism manage anxiety and obsessive-compulsive disorders. Unlike other treatments, CBT can be delivered in a family-based, internet-delivered format, making it more accessible and engaging for autistic youth and their families.611121314
What is the purpose of this trial?
In addition to the core symptoms, children and adolescents with Autism Spectrum Disorder (ASD) often exhibit disruptive behavior problems including irritability, tantrums, noncompliance, and aggression. The purpose of this study is to investigate cognitive-behavioral therapy (CBT) for disruptive behavior in children with autism spectrum disorders and intellectual disability. This pilot study will include children with ASD and IQ between 55 and 85 in an open study of CBT. CBT is modified in this study to reduce complexity of activities during therapy sessions but retains all key elements and principles of CBT. Assessments of irritability and disruptive behavior will include clinical interviews, parent ratings and child self-report measures. Study participants will be asked to complete functional magnetic resonance imaging (fMRI) to evaluate biomarkers of social perception and emotion regulation before and after CBT.
Research Team
Denis Sukhodolsky, PhD
Principal Investigator
Associate Professor
Eligibility Criteria
This trial is for children with Autism Spectrum Disorder and an IQ between 55 and 85 who show disruptive behaviors like irritability. They must be able to complete study assessments and fMRI scans, either un-medicated or on a stable medication regimen. Children with other medical or psychiatric conditions needing different treatments cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive weekly sessions of Principles-Based Cognitive Behavior Therapy (PB-CBT) for irritability in autism
fMRI Assessment
Participants undergo fMRI scans to evaluate biomarkers of social perception and emotion regulation before and after CBT
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Cognitive-Behavioral Therapy
Find a Clinic Near You
Who Is Running the Clinical Trial?
Yale University
Lead Sponsor